Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain

European Journal of Pharmacology

Volumn 307, Issue 1, 1996, Pages 117-119

  Narita, Natsuko ^a   Hashimoto, Kenji ^a,b   Tomitaka, Shin Ichiro ^a   Minabe, Yoshio ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) reuptake inhibitor; Binding; Brain, rat; Receptor, subytpe

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; NORFLUOXETINE; PAROXETINE; PENTAZOCINE; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIGMA OPIATE RECEPTOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENANTIOMER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0030594575     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00254-3     Document Type: Article

References (14)

1. Blier, P. and C. De Montigny, 1995, Current advances and trends in the treatment of depression, Trends Pharmacol. Sei. 15, 220.
2. 3H](+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors, Mol. Neuropharmacol. 3, 117.
3. Breier, A., 1995, Serotonin, schizophrenia and antipsychotic drug action, Schizophrenia Res. 14, 187.
4. Fuller, R.W., 1992, Basic advances in serotonin pharmacology, J. Clin. Psychiatry, 53 (Suppl.), 36.
5. Goff, D.C., A.W. Brotman, M. Waites and S. McCormick, 1990, Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients, Am. J. Psychiatry 147, 492.
6. Hashimoto, K. and E.D. London, 1995, Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of σ receptors, Eur. J. Pharmacol. 273, 307.
7. 2A receptor by a sigma ligand NE-100, Soc. Neurosci. Abstr. 25, 443.13.
8. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.-P. Su, S.W. Tam and D.P. Taylor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
9. 3H]3-PPP binding to σ sites in rat brain, Eur. J. Pharmacol. 165, 335.
10. Shirayama, Y., T. Nishikawa, A. Umino and K. Takahashi, 1993, p-Chlorophenylalanine-reversible reduction of σ binding sites by chronic imipramine treatment in rat brain, Eur. J. Pharmacol. 37, 117.
11. Su, T.-P., 1993, Delineating biochemical and functional properties of sigma receptors: emerging concepts, Crit. Rev. Neurobiol. 7, 187.
12. Walker, J.M., W.D. Bowen, F.O. Walker, R.R. Matsumoto, B.R De Costa and K.C. Rice, 1991, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
13. Wong, D.T., P.P. Bymaster and E.A. Engleman, 1995, Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication, Life Sci. 57, 411.
14. Wong, D.T., P.P. Bymaster, L.R. Reid, D.A. Mayle, J.H. Krushinski and D.W. Robertson, 1993, Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain, Neuropsychopharmacology 8, 337.